Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IIB Dose Response and Safety Study of Topical Formulations of Methotrexate (MQX-5902, MQX-5904 and MQX-5906) in the Treatment of Fingernail Psoriasis

NCT00666354 is registered in ClinicalTrials.gov with MediQuest Therapeutics as lead sponsor.

NCT NCT00666354
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00666354 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IIB Dose Response and Safety Study of Topical Formulations of Methotrexate (MQX-5902, MQX-5904 and MQX-5906) in the Treatment of Fingernail Psoriasis
Lead sponsor
MediQuest Therapeutics
Phase
Phase 2
Overall status
Unknown status
Start date
October 31, 2007
Completion date
January 31, 2009
Enrollment
83 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

fingernail psoriasis